Check out our most popular compounded medications! Get Started
Active pharmaceutical ingredient

Diphenylcyclopropenone

Diphenylcyclopropenone (DPCP, diphencyprone) is a topical contact sensitizer used in skin immunotherapy; compounded preparations require a prescription and are not FDA-approved.

About this ingredient

Diphenylcyclopropenone, also called diphencyprone or DPCP, is a chemical that sensitizes the skin and triggers an allergic contact reaction where it is applied. No FDA-approved drug product contains it: Drugs@FDA lists no application, DailyMed has no product label, and the FDA NDC directory lists only a bulk powder marketed for human prescription compounding. FDA regulations include diphenylcyclopropenone, for topical use only, on the list of bulk drug substances that can be used in compounding under section 503A. Its use for alopecia areata was reported by Happle and colleagues in 1983, and DermNet notes that some dermatology centers use it and that it may be useful for hard to treat warts. One idea is that the induced skin reaction draws immune activity away from hair follicles, but how it acts has not been established. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

Because there is no FDA-approved product, there is no FDA label with boxed warnings or interaction lists. DPCP is meant to cause a skin reaction, so mild redness and itching are expected. A 2021 review lists dermatitis and hives among its side effects, along with swelling (angioedema), severe allergic reactions, fever and erythema multiforme-like reactions. Severe reactions can include burning, blistering and swelling, swollen lymph nodes behind the ears, and lasting pigment changes, including loss of skin color (vitiligo). Gloves should be worn for each application, because a partner or health care worker can also become sensitized. Treated skin should be covered for the first 24 hours, since sunlight breaks DPCP down. DermNet advises against use in pregnancy or when planning pregnancy because safety data are lacking. No lactation data source was found. For side effects, talk to your prescriber or pharmacist.

DPCP is a contact sensitizer for topical immunotherapy. Proposed mechanisms in alopecia areata include antigenic competition, in which induced allergic contact dermatitis redirects T cell activity away from the hair follicle, and a shift in cytokines toward a regulatory profile; a 2021 review states both need further evidence. The protocol described in a 2021 review is an initial sensitization application followed by weekly applications at a low starting strength titrated to the skin reaction; strengths per prescriber. DPCP is reported as nonmutagenic in the Ames assay with no reported systemic absorption, though DermNet notes its precursor and possible manufacturing contaminant, alpha,alpha'-dibromodibenzyl ketone, can be mutagenic. DermNet advises storing it in a dark glass bottle away from sunlight, and a 2021 review describes amber glass storage away from sunlight for topical sensitizers. Patients with high serum IgE may have more severe reactions. A 2021 review describes DPCP immunotherapy for alopecia areata, and a 2013 retrospective study describes its use for periungual warts. These are not FDA-approved indications; no FDA-approved product exists. Strength is adjusted according to the local skin reaction, and DermNet describes potent topical steroids, cool compresses or a short oral steroid course for severe reactions. 21 CFR 216.23 limits 503A compounding with this bulk substance to topical use.

Sources

Compounded at Bayview

How we prepare this ingredient

Patient guides for the preparations we make most often. Each one is compounded to order and requires a prescription.

We do not have a patient page for this ingredient yet. That does not mean we cannot make it. Bayview compounds this ingredient to a prescriber's order, and our full compounding formulary lists every preparation we make. Viewing the formulary requires a prescriber account.

Prescriber sign in

For prescribers

Full formulary with this ingredient

Every preparation in our formulary that contains this ingredient. Strength, base and dose form are set by the prescription.

We compound this ingredient to a prescriber's order. Our full formulary lists every preparation we make with it, including strength, base and dose form. Sign in with a prescriber account to view it.

Prescriber sign in
Common questions

Frequently asked questions

No items found.
Related

Related active ingredients

Other salt forms of this molecule, and ingredients commonly compounded alongside it.

No items found.

Important information

This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.

Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Talk to a compounding pharmacist

Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.